S. Stevanović

H. Rammensee, S. Stevanović, O. Rötzschke, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Matrilysin (MMP-7) Is a Novel Broadly Expressed Tumor Antigen Recognized by Antigen-Specific T Cells

H. Rammensee, S. Stevanović, A. Heine, 2008, Clinical Cancer Research.

Matrilysin ( MMP-7 ) Is a Novel Broadly ExpressedTumorAntigen Recognized byAntigen -

H. Rammensee, S. Stevanović, A. Heine, 2008 .

CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors

H. Rammensee, S. Stevanović, T. Weinschenk, 2005, Cancer Immunology, Immunotherapy.

Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen.

H. Rammensee, S. Stevanović, R. Kalluri, 1996, Kidney international.

The Global Architecture Shaping the Heterogeneity and Tissue-Dependency of the MHC Class I Immunopeptidome is Evolutionarily Conserved

Kevin A. Kovalchik, David J. Hamelin, H. Rammensee, 2020, bioRxiv.

Antitumour activity of Helix hemocyanin against bladder carcinoma permanent cell lines

S. Stevanović, A. Stenzl, W. Aicher, 2019, Biotechnology & Biotechnological Equipment.

Identification of an SSX-2 Epitope Presented by Dendritic Cells to Circulating Autologous CD4+ T Cells1

S. Stevanović, Yao-Tseng Chen, D. Speiser, 2004, The Journal of Immunology.

Erratum to “Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient”

H. Rammensee, S. Stevanović, O. Kohlbacher, 2016, Journal of hepatology.

CD4+ T Cell Responses to SSX-4 in Melanoma Patients1

S. Stevanović, Yao-Tseng Chen, D. Speiser, 2005, The Journal of Immunology.

CD4 T Cell Responses to SSX-4 in Melanoma Patients

S. Stevanović, Yao-Tseng Chen, D. Speiser, 2005 .

Melanoma Patients T Cell Responses to SSX-4 in + CD 4

S. Stevanović, Yao-Tseng Chen, D. Speiser, 2005 .

A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4+ and CD8+ T-cell as well as B-cell responses

S. Stevanović, M. Pfreundschuh, F. Neumann, 2011, Cancer Immunology, Immunotherapy.

The Autophagy Receptor TAX1BP1 (T6BP) improves antigen presentation by MHC‐II molecules

S. Stevanović, O. Delelis, M. Faure, 2022, EMBO reports.

The Autophagy Receptor TAX1BP1 (T6BP) is a novel player in antigen presentation by MHC-II molecules

S. Stevanović, O. Delelis, M. Faure, 2022, bioRxiv.

Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis

S. Stevanović, J. Dengjel, M. Feuchtinger, 2009, Gut.

Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope

S. Stevanović, D. Kanduc, A. Sinha, 2003, Peptides.

Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay.

H. Rammensee, S. Stevanović, C. Scheibenbogen, 1997, International journal of cancer.

Novel Lysophospholipase A Secreted byLegionella pneumophila

S. Stevanović, B. Neumeister, A. Flieger, 2001, Journal of bacteriology.

Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs

V. Gnau, H. Rammensee, S. Stevanović, 2004, Immunogenetics.

Application of the IFN-γ ELISPOT assay to quantify T cell responses against proteins

E. Thiel, S. Stevanović, C. Scheibenbogen, 2001 .

The peptide-specific alloreactive human T cell repertoire varies largely between individuals and is not extended in HLA-A*0205--anti-HLA-A*0201 pairings.

H. Rammensee, S. Stevanović, D. Wernet, 2001, International immunology.

MAGED4 – expression in renal cell carcinoma and identification of an HLA-A*25-restricted MHC class I ligand from solid tumor tissue

H. Rammensee, S. Stevanović, O. Schoor, 2005, Cancer biology & therapy.

Cytotoxic Effects of Rapana venosa Hemocyanin on Bladder Cancer Permanent Cell Lines

S. Stevanović, A. Stenzl, W. Aicher, 2016 .

Antimicrobial Activity of Molluscan Hemocyanins from Helix and Rapana Snails.

S. Stevanović, J. V. Van Beeumen, M. Floetenmeyer, 2016, Current pharmaceutical biotechnology.

Structure of hemocyanin subunit CaeSS2 of the crustacean Mediterranean crab Carcinus aestuarii.

S. Stevanović, S. Savvides, J. V. Van Beeumen, 2005, Journal of biochemistry.

Characterization of the carbohydrate moieties of the functional unit RvH1-a of Rapana venosa haemocyanin using HPLC/electrospray ionization MS and glycosidase digestion.

S. Stevanović, M. Beltramini, B. Salvato, 2003, The Biochemical journal.

Isolation and structure elucidation of the 43-peptide antibiotic microcin B17

S. Stevanović, G. Jung, J. Metzger, 1993 .

Electrospray Mass Spectrometry and Multiple Sequence Analysis of Synthetic Peptide Libraries

S. Stevanović, G. Jung, K. Wiesmüller, 1994 .

HLA-A26 subtype A pockets accommodate acidic N-termini of ligands

H. Rammensee, S. Stevanović, K. Tokunaga, 1998, Immunogenetics.

Multiple sequence analysis of MHC ligands

S. Stevanović, 1996 .

Analytical methods for the characterization of synthetic peptide libraries

S. Stevanović, G. Jung, K. Wiesmüller, 1993 .

Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin.

S. Gygi, S. Stevanović, J. Paulo, 2019, Analytical chemistry.

Antimicrobial activity of peptides from the hemolymph of Helix lucorum snails

S. Stevanović, J. Beeumen, G. Bonchev, 2015 .

The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.

H. Rammensee, S. Stevanović, E. Thorsby, 1996, European journal of immunology.

alpha B-crystallin is a cytoplasmic interaction partner of the kidney-specific cadherin-16.

S. Stevanović, R. Lammers, H. Kalbacher, 2008, Journal of molecular biology.

Biochemical properties of Cu/Zn-superoxide dismutase from fungal strain Aspergillus niger 26.

S. Stevanović, J. V. Van Beeumen, B. Devreese, 2008, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

Positions of the Glycans in Molluscan Hemocyanin, Determined by Fluorescence Spectroscopy

S. Stevanović, P. Dolashka, W. Voelter, 2013, Journal of Fluorescence.

The peptide binding motif of the disease associated HLA‐DQ (α 1* 0501, β 1* 0201) molecule

H. Rammensee, S. Stevanović, E. Thorsby, 1996 .

Broad and Efficient Activation of Memory CD4+ T Cells by Novel HAdV- and HCMV-Derived Peptide Pools

H. Rammensee, S. Stevanović, L. März, 2021, Frontiers in Immunology.

Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers

H. Rammensee, S. Stevanović, O. Kohlbacher, 2018, Leukemia & lymphoma.

The dominantly expressed class II molecule from a resistant MHC haplotype presents only a few Marek’s disease virus peptides by using an unprecedented binding motif

H. Rammensee, S. Stevanović, J. Kaufman, 2021, PLoS biology.

Differential host response to a herpesvirus: Marek’s disease virus peptides on chicken MHC class II molecules are derived from only a few genes and illustrate a new mode of peptide binding

H. Rammensee, S. Stevanović, J. Kaufman, 2020 .

Nonclassical HLA-G molecules are classical peptide presenters

H. Rammensee, S. Stevanović, C. Münz, 1996, Current Biology.

S. Stevanović, G. Pawelec, Q. Ouyang, 2003, Mechanisms of Ageing and Development.

RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs

Amber K Weiner, S. Stevanović, D. Dimitrov, 2021, Nature.

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.

H. Rammensee, S. Stevanović, L. Kanz, 1999, Blood.

o-Diphenol oxidase activity of molluscan hemocyanins.

S. Stevanović, W. Voelter, P. Dolashka-Angelova, 2008, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

A challenging insight on the structural unit 1 of molluscan Rapana venosa hemocyanin.

S. Stevanović, J. V. Van Beeumen, B. Devreese, 2007, Archives of biochemistry and biophysics.

Oligomeric stability of Rapana venosa hemocyanin (RvH) and its structural subunits.

S. Stevanović, H. Schwarz, W. Voelter, 2003, Biochimica et biophysica acta.

RETRACTED ARTICLE: Structure and Characterization of Cancer pagurus Hemocyanin

S. Stevanović, W. Voelter, E. Todorovska, 2015, Marine Biotechnology.

Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells.

S. Stevanović, M. Pfreundschuh, C. Wagner, 2005, Blood.

Structure of hemocyanin from garden snail Helix lucorum.

S. Stevanović, H. Schwarz, I. Dimitrov, 2010, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

Structure and stability of arthropodan hemocyanin Limulus polyphemus.

S. Stevanović, B. Atanasov, P. Nikolov, 2005, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

Identification of glycosylated sites in Rapana hemocyanin by mass spectrometry and gene sequence, and their antiviral effect.

S. Stevanović, J. V. Van Beeumen, B. Devreese, 2009, Bioconjugate chemistry.

Reversibility and "pH-T phase diagrams" of Rapana venosa hemocyanin and its structural subunits.

S. Stevanović, B. Atanasov, H. Schwarz, 2008, Biochimica et biophysica acta.

Bioactive compounds isolated from garden snails

S. Stevanović, P. Traldi, L. Molin, 2015 .

Immunological Potential of Helix vulgaris and Rapana venosa Hemocyanins

S. Stevanović, H. Neychev, W. Voelter, 2008, Immunological investigations.

Structure and Characterization of Eriphia verrucosa Hemocyanin

S. Stevanović, L. Molin, E. Todorovska, 2015, Marine Biotechnology.

Carbohydrate moieties of molluscan Rapana venosa hemocyanin.

S. Stevanović, M. Beltramini, W. Voelter, 2004, Micron.

Changes in the gene expression profile of the bladder cancer cell lines after treatment with Helix lucorum and Rapana venosa hemocyanin.

S. Stevanović, D. Toncheva, L. Yossifova, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Structure and Characterization of Eriphia verrucosa Hemocyanin

S. Stevanović, L. Molin, P. Traldi, 2015, Marine Biotechnology.

Substrate specificity of cathepsins D and E determined by N-terminal and C-terminal sequencing of peptide pools.

H. Rammensee, S. Stevanović, H. Schild, 1997, European journal of biochemistry.

Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA‐B44 supertype

Nina Hillen, Arnulf Stenzl, Dorothee Wernet, 2008, European journal of immunology.

Proteome Analysis by Three-Dimensional Protein Separation: Turnover of Cytosolic Proteins in Hepatocytes

S. Stevanović, P. Bohley, Peter Bohley, 2001, Biological chemistry.

A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays.

H. Rammensee, S. Stevanović, O. Schoor, 2008, Cancer research.

Recognition by Immune Cells

H. Rammensee, J. Bachmann, S. Stevanović, 1997 .

A mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group (NOA-16).

S. Stevanović, W. Wick, G. Tabatabai, 2016 .

The MHC Genes

H. Rammensee, J. Bachmann, S. Stevanović, 1997 .

Autophagy promotes MHC class II presentation of peptides from intracellular source proteins

H. Rammensee, S. Stevanović, O. Schoor, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Tumor-associated MICA is shed by ADAM proteases.

H. Rammensee, S. Stevanović, A. Ludwig, 2008, Cancer research.

A vaccine targeting mutant IDH1 in newly diagnosed glioma

S. Stevanović, I. Harting, S. Justesen, 2021, Nature.

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

H. Rammensee, S. Stevanović, M. Weller, 2021, Journal for ImmunoTherapy of Cancer.

Molecular Modeling of Eluted Peptides from DQ6 Molecules (DQB1*0602 and DQB1*0604) Negatively and Positively Associated with Type 1 Diabetes

T. Lybrand, H. Rammensee, S. Stevanović, 2002, Annals of the New York Academy of Sciences.

PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

T. Lybrand, H. Rammensee, S. Stevanović, 2002 .

Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis.

V. Gnau, H. Rammensee, S. Stevanović, 1993, International immunology.

The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy

H. Rammensee, S. Stevanović, M. Weller, 2018, Acta Neuropathologica.

Carcinogenesis of renal cell carcinoma reflected in HLA ligands: A novel approach for synergistic peptide vaccination design

H. Rammensee, S. Stevanović, A. Stenzl, 2016, Oncoimmunology.

Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome

R. Aebersold, H. Rammensee, S. Stevanović, 2020, Journal of proteome research.

Actively personalized vaccination trial for newly diagnosed glioblastoma

J. Castle, H. Rammensee, S. Stevanović, 2018, Nature.

Immunogenicity and Immune Silence in Human Cancer

S. Stevanović, P. Raman, D. Monos, 2019, SSRN Electronic Journal.

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

H. Rammensee, S. Stevanović, B. Maček, 2019, Genome medicine.

HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.

M. Okoniewski, H. Rammensee, S. Stevanović, 2013, Brain : a journal of neurology.

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

S. Stevanović, E. Rieber, G. Schackert, 2007, British Journal of Cancer.

Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients

S. Stevanović, E. Rieber, M. Wirth, 2002, International journal of cancer.

Characterization of an Aminopeptidase and a Proline Iminopeptidase from Cabbage Leaves

S. Stevanović, W. Voelter, M. Marinova, 2008, Zeitschrift fur Naturforschung. C, Journal of biosciences.

Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling

H. Rammensee, S. Stevanović, C. Lemmel, 2004, Nature Biotechnology.

The Impact of Biomaterial Cell Contact on the Immunopeptidome

H. Rammensee, S. Stevanović, L. Bichmann, 2020, Frontiers in Bioengineering and Biotechnology.

Characterization of BAX inhibitor-1 as a novel leukemia-associated antigen

S. Stevanović, T. Holderried, A. Heine, 2009, Leukemia.

Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11.

S. Stevanović, E. Rieber, M. Rieger, 2007, Cancer letters.

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

H. Rammensee, S. Stevanović, M. Haag, 2020, Genome Medicine.

Identification of an HLA‐A*0201‐restricted T‐cell epitope derived from the prostate cancer‐associated protein trp‐p8

S. Stevanović, E. Rieber, M. Wirth, 2003 .

Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands

Hans-Georg Rammensee, Marcus Groettrup, Lothar Kuehn, 1996, Cell.

Regulatory T Cells in an Endogenous Mouse Lymphoma Recognize Specific Antigen Peptides and Contribute to Immune Escape

S. Stevanović, M. Röcken, N. Trautwein, 2019, Cancer Immunology Research.

Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals

S. Stevanović, D. Valmori, M. Ayyoub, 2007, Cancer Immunology, Immunotherapy.

Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).

D. Jewell, A. Hill, H. Rammensee, 1997, International immunology.

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy

H. Rammensee, S. Stevanović, L. Kanz, 2016, Oncoimmunology.

Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides.

H. Rammensee, S. Stevanović, E. Rieber, 2000, Cancer research.

High Immune Response Rates and Decreased Frequencies of Regulatory T Cells in Metastatic Renal Cell Carcinoma Patients after Tumor Cell Vaccination

S. Stevanović, C. Stief, G. Willimsky, 2012, Molecular medicine.

Immunotherapy of renal cell carcinoma

H. Rammensee, S. Stevanović, A. Stenzl, 2006, Cancer Immunology, Immunotherapy.

MHCquant: Automated and reproducible data analysis for immunopeptidomics.

Timo Sachsenberg, Oliver Kohlbacher, Alexander Peltzer, 2019, Journal of proteome research.

The SysteMHC Atlas project

Roman A. Zubarev, Emanuel Schmid, Witold Wolski, 2017, Nucleic Acids Res..

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

Oliver Kohlbacher, Sven Nahnsen, Mathias Walzer, 2016, Journal of hepatology.

Integrated functional genomics approach for the design of patient-individual antitumor vaccines.

Hans-Georg Rammensee, Cécile Gouttefangeas, Steffen Walter, 2002, Cancer research.

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

H. Rammensee, S. Stevanović, O. Kohlbacher, 2020, Nature immunology.

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

H. Rammensee, S. Stevanović, H. Salih, 2021, Science Translational Medicine.

Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma

S. Stevanović, Malte Roerden, A. Nelde, 2020, Blood Cancer Journal.

Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma

H. Rammensee, S. Stevanović, S. Nahnsen, 2018, Molecular therapy oncolytics.

Moderate degradation does not preclude microarray analysis of small amounts of RNA.

Hans-Georg Rammensee, Arnulf Stenzl, Jörg Hennenlotter, 2003, BioTechniques.

Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy

H. Rammensee, S. Stevanović, O. Schoor, 2005, Cancer Immunology, Immunotherapy.

Patient-individual Antitumor Vaccines Integrated Functional Genomics Approach for the Design of Updated

H. Rammensee, S. Stevanović, M. Schirle, 2002 .

Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants

S. Stevanović, B. Maček, C. Wolz, 2016, Nature Communications.

Structural basis of immunogenicity.

S. Stevanović, 2002, Transplant immunology.

Exploring the MHC-peptide matrix of central tolerance in the human thymus

Nina Hillen, Stefan Tenzer, Eva Tolosa, 2013, Nature Communications.

A Naturally Processed Rat Major Histocompatibility Complex Class I-associated Viral Peptide as Target Structure of Borna Disease Virus-specific CD8+ T Cells*

S. Stevanović, M. Schirle, L. Stitz, 2001, The Journal of Biological Chemistry.

Identification of HLA-A*01- and HLA-A*02-restricted CD8+ T-cell epitopes shared among group B enteroviruses.

H. Rammensee, S. Stevanović, A. Weinzierl, 2008, The Journal of general virology.

Peptide motifs of closely related HLA class I molecules encompass substantial differences

H. Rammensee, S. Stevanović, O. Rötzschke, 1992, European journal of immunology.

Preferred size of peptides that bind to H‐2 Kb is sequence dependent

Georg Greiner, S. Stevanović, T. Schumacher, 1992, European journal of immunology.

Two new proteases in the MHC class I processing pathway

Hans-Georg Rammensee, H. Rammensee, S. Stevanović, 2000, Nature Immunology.

The Human 26 S and 20 S Proteasomes Generate Overlapping but Different Sets of Peptide Fragments from a Model Protein Substrate*

Hans-Georg Rammensee, H. Rammensee, N. Emmerich, 2000, The Journal of Biological Chemistry.

MHC Ligands and Peptide Motifs

Hans-Georg Rammensee, Jutta Bachmann, H. Rammensee, 1998, Molecular Biology Intelligence Unit.

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines

Hans-Georg Rammensee, Burkhard Schmidt, François A. Lemonnier, 2002, Proceedings of the National Academy of Sciences of the United States of America.

BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity

S. Stevanović, Hao Wu, E. Latz, 2019, bioRxiv.

Mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons

F. Zufall, H. Rammensee, S. Stevanović, 2013, Nature Communications.

An example of immunodominance: engagement of synonymous TCR by invariant CDR3 beta.

S. Stevanović, H. Schild, G. Jung, 2000, International immunology.

A natural tapasin isoform lacking exon 3 modifies peptide loading complex function

S. Stevanović, E. Ghanem, H. Hanenberg, 2013, European journal of immunology.

Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft–host interaction

H. Rammensee, S. Stevanović, L. Kanz, 2016, Proceedings of the National Academy of Sciences.

Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.

W Keilholz, R. Huber, H. Rammensee, 1998, Proceedings of the National Academy of Sciences of the United States of America.

HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis

Nora C. Toussaint, H. Rammensee, S. Stevanović, 2020, Cell.

HIV-1 induced changes in HLA-C∗03 : 04-presented peptide repertoires lead to reduced engagement of inhibitory natural killer cell receptors

M. Altfeld, S. Stevanović, T. Huynh, 2020, AIDS.

Mass spectrometric identification of an HLA-A*0201 epitope from Plasmodium falciparum MSP-1.

S. Stevanović, C. Lemmel, S. Pascolo, 2008, International immunology.

Analysis of allele-specific contact sites of natural HLA-DR17 ligands.

V. Gnau, H. Rammensee, S. Stevanović, 1994, Journal of immunology.

An innovative approach for HLA typing, molecular tumor testing and the validation of tumor exclusive antigens

H. Rammensee, S. Stevanović, O. Kohlbacher, 2020, bioRxiv.

Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two- residue contact motif

S. Stevanović, H. Kalbacher, G. Jung, 1992, The Journal of experimental medicine.

Contribution of mass spectrometry-based proteomics to immunology

Nina Hillen, S. Stevanović, Stefan Stevanovic, 2006, Expert review of proteomics.

Autophagy in innate and adaptive immunity against intracellular pathogens

S. Stevanović, O. Schoor, J. Dengjel, 2006, Journal of Molecular Medicine.

Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt’s Lymphoma Cells1

S. Stevanović, S. Nikiforow, W. Hanekom, 2002, The Journal of Immunology.

Multiple sequence analysis: pool sequencing of synthetic and natural peptide libraries.

S. Stevanović, G. Jung, 1993, Analytical biochemistry.

TAPBPR bridges UDP-glucose:glycoprotein glucosyltransferase 1 onto MHC class I to provide quality control in the antigen presentation pathway

S. Stevanović, T. Elliott, N. Trautwein, 2017, eLife.

Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers

B. Gückel, S. Stevanović, D. Wallwiener, 2006, Journal of Cancer Research and Clinical Oncology.

The use of HPLC-MS in T-cell epitope identification.

S. Stevanović, C. Lemmel, 2003, Methods.

HLA-A2 subtypes are functionally distinct in peptide binding and presentation

H. Rammensee, S. Stevanović, S. Rowland-Jones, 1995, The Journal of experimental medicine.

Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens.

J P Cazenave, H. Rammensee, S. Stevanović, 1997, Journal of immunology.

Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin

S. Stevanović, H. Sahl, T. Kupke, 1992, Journal of bacteriology.

Ferredoxin:NADP oxidoreductase of Cyanophora paradoxa: purification, partial characterization, and N-terminal amino acid sequence.

S. Stevanović, M. Bayer, T. Maier, 1992, Protein expression and purification.

Definition of peptide binding motifs amongst the HLA-A*30 allelic group.

H. Rammensee, S. Stevanović, A. McMichael, 2000, Tissue antigens.

Clearance of Chlamydia pneumoniae Infection in H‐2 Class I–/– Human Leucocyte Antigen‐A2.1 Monochain Transgenic Mice

H. Rammensee, S. Stevanović, R. Lahesmaa, 2005, Scandinavian journal of immunology.

Identification of Chlamydia pneumoniae-Derived Mouse CD8 Epitopes

Hans-Georg Rammensee, H. Rammensee, S. Stevanović, 2002, Infection and Immunity.

Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein

S. Stevanović, E. Rieber, S. Füssel, 2004, British Journal of Cancer.

Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy

H. Rammensee, S. Stevanović, O. Schoor, 2013, Journal of Neuro-Oncology.

A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry.

B. Gückel, H. Rammensee, S. Stevanović, 2001, Cancer research.

High-density preculture of PBMCs restores defective sensitivity of circulating CD8 T cells to virus- and tumor-derived antigens.

S. Stevanović, C. Scholz, S. Hackenberg, 2015, Blood.

Induction of HA‐1‐specific cytotoxic T‐cell clones parallels the therapeutic effect of donor lymphocyte infusion

H. Rammensee, S. Stevanović, K. Grünewald, 2002, British journal of haematology.

Induction of Thelper1-driven Antiviral T-cell Lines for Adoptive Immunotherapy Is Determined by Differential Expression of IFN-&ggr; and T-cell Activation Markers

S. Stevanović, R. Handgretinger, J. Leibold, 2012, Journal of immunotherapy.

Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(HELPER) cells following stem cell transplantation.

H. Rammensee, S. Stevanović, R. Handgretinger, 2010, Virology.

Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.

D. Schadendorf, P. Kloetzel, S. Stevanović, 2002, Cancer research.

CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT

S. Stevanović, H. Einsele, T. Tonn, 2009, Bone Marrow Transplantation.

Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis

H. Rammensee, S. Stevanović, O. Schoor, 2004, Cancer Research.

Identification of α-tubulin as an autoantigen recognized by sera from patients with neuropsychiatric systemic lupus erythematosus

S. Stevanović, J. Dengjel, R. Klein, 2011, Brain, Behavior, and Immunity.

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

H. Rammensee, S. Stevanović, B. Pichler, 2019, Journal of Immunotherapy for Cancer.

Targeting self and neo-epitopes with a modular self-adjuvanting cancer vaccine.

S. Stevanović, P. Walker, M. Derouazi, 2019, JCI insight.

Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy

H. Rammensee, S. Stevanović, L. Kanz, 2015, Leukemia.

Cathepsin S and an asparagine‐specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro

Martin Deeg, S. Stevanović, M. Deeg, 2001, European journal of immunology.

Identification of tumour-associated t-cell epitopes for vaccine development

S. Stevanović, 2002, Nature Reviews Cancer.

Promiscuous survivin peptide induces robust CD4+ T‐cell responses in the majority of vaccinated cancer patients

H. Rammensee, S. Stevanović, A. Stenzl, 2012, International journal of cancer.

HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under In Vitro Lenalidomide Treatment Confirms Lenalidomide as a Suitable Combination Partner for T-Cell Based Immunotherapy

H. Rammensee, S. Stevanović, L. Kanz, 2016 .

Short-Term In-Vitro Expansion Improves Monitoring and Allows Affordable Generation of Virus-Specific T-Cells against Several Viruses for a Broad Clinical Application

H. Rammensee, S. Stevanović, T. Lion, 2013, PloS one.

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays

A. Mackensen, C. Gouttefangeas, A. Mander, 2007, Cancer Immunology, Immunotherapy.

Cutting Edge: Predetermined Avidity of Human CD8 T Cells Expanded on Calibrated MHC/Anti-CD28-Coated Microspheres 1

Hans-Georg Rammensee, Gundram Jung, Steffen Walter, 2003, The Journal of Immunology.

EpiToolKit—a web server for computational immunomics

Oliver Kohlbacher, Stefan Stevanovic, Magdalena Feldhahn, 2008, Nucleic Acids Res..

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

S. Stevanović, E. Rieber, G. Schackert, 2007, British Journal of Cancer.

Novel multi‐peptide vaccination in Hla‐A2+ hormone sensitive patients with biochemical relapse of prostate cancer

Cécile Gouttefangeas, Klaus Dietz, Arnulf Stenzl, 2009, The Prostate.

Identification of an Immunogenic HLA-A*0201-binding T-cell Epitope of the Transcription Factor PAX2

E. Thiel, H. Rammensee, S. Stevanović, 2009, Journal of immunotherapy.

Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1

E. Thiel, H. Rammensee, S. Stevanović, 2006, Clinical Cancer Research.

Long-Term Immunity against Actual Poxviral HLA Ligands as Identified by Differential Stable Isotope Labeling1

H. Rammensee, S. Stevanović, W. Kastenmuller, 2008, The Journal of Immunology.

Generation of RAGE‐1 and MAGE‐9 peptide‐specific cytotoxic T‐Lymphocyte lines for transfer in patients with renal cell carcinoma

S. Stevanović, M. Zöller, M. Linnebacher, 2005, International journal of cancer.

Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas

H. Rammensee, S. Stevanović, O. Schoor, 2006, Clinical Cancer Research.

Melanoma patients respond to a new HLA‐A*01‐presented antigenic ligand derived from a multi‐epitope region of melanoma antigen TRP‐2

D. Schadendorf, S. Stevanović, G. Sutter, 2005, International journal of cancer.

Gene delivery by attenuated Salmonella typhimurium : Comparing the efficacy of helper versus cytotoxic T cell priming in tumor vaccination

S. Stevanović, M. Zöller, O. Christ, 2001, Cancer Gene Therapy.

Dendritic Cells Pulsed with Protein or Selected Peptides T Effector Cells by + Generation of Survivin-specific CD 8 Updated

H. Rammensee, S. Stevanović, E. Rieber, 2000 .

Identification of known and novel immunogenic T‐cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL‐2‐based treatment

D. Schadendorf, E. Thiel, H. Rammensee, 2002, International journal of cancer.

Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins.

E. Thiel, S. Stevanović, C. Scheibenbogen, 2001, Journal of immunological methods.

High frequencies of functionally impaired cytokeratin 18‐specific CD8+ T cells in healthy HLA‐A2+ donors

H. Rammensee, S. Stevanović, G. Pawelec, 2005, European journal of immunology.

Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.

S. Stevanović, S Stevanović, H Schild, 1999, Seminars in immunology.

Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes

H. Rammensee, S. Stevanović, M. Pfreundschuh, 2004, Cancer Immunology, Immunotherapy.

A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapy

S. Stevanović, J. Peper, 2015, Cancer Immunology, Immunotherapy.

Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2.

S. Stevanović, Yao-Tseng Chen, D. Speiser, 2005, Clinical immunology.

Identification of an HLA‐DR‐restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM‐MEL‐40/SSX2

S. Stevanović, M. Pfreundschuh, C. Wagner, 2004, International journal of cancer.

Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2.

H. Rammensee, S. Stevanović, M. Pfreundschuh, 2003, Cancer immunity.

MelanomaTumor-Reactive CTL Infiltrating Metastatic SSX-2-Derived Epitope Recognized by Proteasome-Assisted Identification of a

H. Rammensee, S. Stevanović, M. Pfreundschuh, 2002 .

The making of the dominant MHC class I ligand SYFPEITHI

H. Rammensee, S. Stevanović, H. Schild, 1998, European journal of immunology.

Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia

H. Rammensee, S. Stevanović, D. Niederwieser, 2008, Leukemia.

ORIGINAL ARTICLE Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia

H. Rammensee, S. Stevanović, Eberhard Karls, 2008 .

Cell lines transfected with the TAP inhibitor ICP47 allow testing peptide binding to a variety of HLA class I molecules.

H. Rammensee, S. Stevanović, H. Schild, 1998, International immunology.

Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules

Hans-Georg Rammensee, H. Rammensee, S. Stevanović, 2004, Immunogenetics.

Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells

F. Marincola, S. Stevanović, B. Seliger, 2011, Proteomics.

Identification and Characterization of T-Cell Epitopes Deduced from RGS 5 , a Novel Broadly ExpressedTumorAntigen

H. Rammensee, S. Stevanović, P. Brossart, 2007 .

A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation.

H. Rammensee, S. Stevanović, H. Einsele, 2003, Experimental hematology.

Alloreactivity as a source of high avidity peptide-specific human CTL.

H. Rammensee, S. Stevanović, R. Obst, 1999, Journal of immunology.

MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies.

Morten Nielsen, Prathyusha Konda, Shashi Gujar, 2017, Journal of proteome research.

Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands

S. Stevanović, Gabor Mester, Stefan Stevanović, 2011, Cellular and Molecular Life Sciences.

TAPBPR mediates peptide dissociation from MHC class I using a leucine lever

S. Stevanović, C. Hermann, A. Marcu, 2018, bioRxiv.

Naturally Presented Peptides on Major Histocompatibility Complex I and II Molecules Eluted from Central Nervous System of Multiple Sclerosis Patients*

Robert Weissert, H. Rammensee, S. Stevanović, 2009, Molecular & Cellular Proteomics.

Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

H. Rammensee, S. Stevanović, J. Dengjel, 2007, The Journal of clinical investigation.

An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells.

H. Rammensee, S. Stevanović, B. Schmid-Horch, 2014, Journal of immunological methods.

Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire

H. Rammensee, S. Stevanović, L. Herrgen, 2004, Cellular and Molecular Life Sciences CMLS.

High frequency of human cytomegalovirus (HCMV)-specific CD8+-T cells detected in a healthy CMV-seropositive donor

H. Rammensee, S. Stevanović, C. Gouttefangeas, 2002, Cellular and Molecular Life Sciences CMLS.

Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.

H. Rammensee, S. Stevanović, H. Einsele, 2002, Blood.

Ex vivo generation of human cytomegalovirus‐specific cytotoxic T cells by peptide‐pulsed dendritic cells

S. Stevanović, H. Einsele, L. Kanz, 2001, British journal of haematology.

Identification of Naturally Processed Hepatitis C Virus-Derived Major Histocompatibility Complex Class I Ligands

Volker Brass, Hans-Georg Rammensee, Darius Moradpour, 2012, PloS one.

Dipeptides catalyze rapid peptide exchange on MHC class I molecules

H. Rammensee, S. Stevanović, S. Saini, 2014, Proceedings of the National Academy of Sciences.

Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation

H. Rammensee, S. Stevanović, K. Klingel, 2011, BMC urology.

ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS

S. Stevanović, I. Harting, W. Wick, 2018, Neuro-Oncology.

HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy

B. Gückel, H. Rammensee, S. Stevanović, 2015, Oncoimmunology.

Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters

Cliburn Chan, Hans-Georg Rammensee, Cedrik M. Britten, 2015, Cancer Immunology, Immunotherapy.

Purification and Identification of Naturally Presented MHC Class I and II Ligands.

S. Stevanović, D. Kowalewski, Annika Nelde, 2019, Methods in molecular biology.

The Role of Peptides in T Cell Alloreactivity Is Determined by Self–Major Histocompatibility Complex Molecules

H. Rammensee, S. Stevanović, R. Obst, 2000, The Journal of experimental medicine.

HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy

Oliver Kohlbacher, Hans-Georg Rammensee, Annika Nelde, 2017, Oncoimmunology.

Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini

H. Rammensee, S. Stevanović, O. Kohlbacher, 2016, Blood Cancer Journal.

HLA ligand profiles of primary renal cell carcinoma maintained in metastases

H. Rammensee, S. Stevanović, A. Weinzierl, 2009, Cancer Immunology, Immunotherapy.

Peptide motif of HLA-B*1510

H. Rammensee, S. Stevanović, M. Schirle, 1999, Immunogenetics.

The HLA-B* 1516 motif demonstrates HLA-B-specific P2 pocket characteristics

H. Rammensee, S. Stevanović, H. Schild, 1998, Immunogenetics.

Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.

H. Rammensee, S. Stevanović, P. Adam, 2018, Cancer research.

Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells

E. Bonifacio, H. Rammensee, S. Stevanović, 2017, Haematologica.

Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases.

H. Rammensee, S. Stevanović, A. Stenzl, 2017, European urology focus.

Efficacy of Imiquimod-Based Transcutaneous Immunization Using a Nano-Dispersed Emulsion Gel Formulation

S. Stevanović, S. Tenzer, H. Schild, 2014, PloS one.

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

S. Stevanović, O. Kohlbacher, J. Karbach, 2020, Nature Immunology.

NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope

S. Stevanović, F. Fanizzi, D. Kanduc, 2004, Peptides.

Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters.

S. Stevanović, L. Kanz, W. Brugger, 1999, Proceedings of the National Academy of Sciences of the United States of America.

T-cell epitope prediction based on self-tolerance

Oliver Kohlbacher, Stefan Stevanovic, Magdalena Feldhahn, 2011, BCB '11.

SNEP: SNP-derived Epitope Prediction program for minor H antigens

Oliver Kohlbacher, Hans-Georg Rammensee, Pierre Dönnes, 2005, Immunogenetics.

A MAGE-A 1 HLA-A * 0201 Epitope Identified by Mass Spectrometry 1

B. Gückel, H. Rammensee, S. Stevanović, 2001 .

The HLA Ligand Atlas: A novel immuno-oncology resource for T-cell antigen discovery.

H. Rammensee, S. Stevanović, M. Weller, 2020 .

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

H. Rammensee, S. Stevanović, M. Haag, 2020, Genome Medicine.

Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients

H. Rammensee, S. Stevanović, O. Kohlbacher, 2019, Novel Vaccine Platforms and Combinations.

GAPVAC-101: First-in-human trial of a highly personalized peptide vaccination approach for patients with newly diagnosed glioblastoma.

H. Rammensee, S. Stevanović, W. Wick, 2018 .

Definition and Characterization of a Peptide Warehouse for the Patient-Individualized Peptide Vaccination Study (iVAC-L-CLL01) after First Line Therapy of CLL

H. Rammensee, S. Stevanović, L. Kanz, 2017 .

Establishing MHC class I peptide motifs.

S. Stevanović, N. Trautwein, 2013, Methods in molecular biology.

Mass Spectrometry Reveals Changes in MHC I Antigen Presentation After Lentivector Expression of a Gene Regulation System

S. Stevanović, J. Mallet, D. Charron, 2013, Molecular therapy. Nucleic acids.

Antigens in water-in-oil emulsion: a simple antigen extraction method for analysis and proof of equal antigen distribution in vaccination syringe after mixture

H. Rammensee, S. Stevanović, Michael Ghosh, 2020, bioRxiv.

Multiple synergizing factors contribute to the strength of the CD8+ T cell response against listeriolysin O.

S. Stevanović, M. Schirle, H. Schild, 2006, International immunology.

Integrin activation enables simultaneous and sensitive detection of functional virus-specific CD4+ and CD8+ T cells

J. Born, H. Rammensee, S. Stevanović, 2020 .

The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes.

D. Schadendorf, S. Stevanović, K. Cichutek, 2006, Blood.

Quantitative Analysis of Prion-Protein Degradation by Constitutive and Immuno-20S Proteasomes Indicates Differences Correlated with Disease Susceptibility1

Hans-Georg Rammensee, Stefan Tenzer, H. Rammensee, 2004, The Journal of Immunology.

Susceptibility Differences Correlated with Disease Immuno-20 S Proteasomes Indicates Degradation by Constitutive and Quantitative Analysis of Prion-Protein and Hansjörg

H. Rammensee, S. Stevanović, B. Schönfisch, 2003 .

Identification of a Novel Immunodominant HLA-B*07: 02-restricted Adenoviral Peptide Epitope and Its Potential in Adoptive Transfer Immunotherapy

M. Neuenhahn, D. Busch, S. Stevanović, 2015, Journal of immunotherapy.

Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans.

J. Latgé, S. Stevanović, H. Einsele, 2011, Blood.

Candida albicans and Aspergillus fumigatus 1 immunity against H Cross-protective T

J. Latgé, S. Stevanović, H. Einsele, 2011 .

Alternative Variants of Human HYDIN Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity

H. Rammensee, S. Stevanović, S. Nedospasov, 2013, Cancer Immunology Research.

Human CD4+ T Lymphocytes Recognize a Vascular Endothelial Growth Factor Receptor-2–Derived Epitope in Association with HLA-DR

D. Schadendorf, S. Stevanović, J. Karbach, 2008, Clinical Cancer Research.

Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo.

H. Rammensee, S. Stevanović, T. Elliott, 2000, Tissue antigens.

Release of matrix metalloproteinase-8 during physiological trafficking and induced mobilization of human hematopoietic stem cells.

S. Stevanović, H. Abele, J. Wessels, 2013, Stem cells and development.

Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites.

S. Stevanović, C. Garbe, A. Humeny, 2006, The Journal of investigative dermatology.

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. 1991.

H. Rammensee, S. Stevanović, O. Rötzschke, 2006, Journal of immunology.

Demonstration of autoantibodies to recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance

S. Stevanović, C. Berg, M. Gregor, 2007, Clinical and experimental immunology.

A 14-3-3 protein of Chlamydomonas reinhardtii associated with the endoplasmic reticulum: nucleotide sequence of the cDNA and the corresponding gene and derived amino acid sequence.

S. Stevanović, M. Schirle, O. Marquardt, 2004, Biochimica et biophysica acta.

Relevance of the inner mitochondrial membrane enzyme F1F0‐ATPase as an autoantigen in autoimmune liver disorders

S. Stevanović, C. Berg, J. Dengjel, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Glycan side chains on naturally presented MHC class II ligands.

H. Rammensee, S. Stevanović, J. Dengjel, 2005, Journal of mass spectrometry : JMS.

Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis.

P. Kloetzel, S. Stevanović, K. Stangl, 2009, The American journal of pathology.

Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies.

H. Rammensee, S. Stevanović, A. Marcu, 2020, Molecular & cellular proteomics : MCP.

Interaction analyses of human monocytes co-cultured with different forms of Aspergillus fumigatus.

S. Stevanović, H. Einsele, M. Bonin, 2009, Journal of medical microbiology.

Characterization of MHC ligands for peptide based tumor vaccination.

S. Stevanović, Felix Klug, H. Schmidt, 2009, Current pharmaceutical design.

Porin of Rhodobacter capsulatus: Biochemical and Functional Characterization

S. Stevanović, J. Rosenbusch, R. Benz, 1990, Zeitschrift fur Naturforschung. C, Journal of biosciences.

Legionella pneumophila Secretes Different Phospholipases A

S. Stevanović, H. Northoff, B. Neumeister, 2002 .

Cathepsin D Is Present in Human Eccrine Sweat and Involved in the Postsecretory Processing of the Antimicrobial Peptide DCD-1L*

S. Stevanović, C. Garbe, H. Dihazi, 2006, Journal of Biological Chemistry.

Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma

H. Rammensee, S. Stevanović, H. Salih, 2020, Blood Cancer Journal.

Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation.

S. Stevanović, G. Panayotou, O. Tsitsilonis, 2007, Proteomics.

Identification of an HLA‐A*0201‐restricted T‐cell epitope derived from the prostate cancer‐associated protein trp‐p8

S. Stevanović, E. Rieber, M. Wirth, 2003, The Prostate.

Abstract 2396: IMA950: A novel multi-peptide cancer vaccine for treatment of glioblastoma

H. Rammensee, S. Stevanović, O. Schoor, 2010 .

CD8+ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patients.

H. Rammensee, S. Stevanović, O. Schoor, 2005, International immunology.

Purification and characterization of EpiA, the peptide substrate for post-translational modifications involved in epidermin biosynthesis.

S. Stevanović, B. Ottenwälder, G. Jung, 1993, FEMS microbiology letters.

Natural and synthetic peptide pools: Characterization by sequencing and electrospray mass spectrometry

S. Stevanović, G. Jung, K. Wiesmüller, 1993 .

Regulation of epidermin biosynthetic genes by EpiQ

S. Stevanović, A. Peschel, T. Kupke, 1993, Molecular microbiology.

Antibodies detecting gene products involved in lantibiotic biosynthesis

S. Stevanović, H. Sahl, G. Jung, 1993 .

76 Clinical and immunological monitoring of a multi-peptide vaccination trial in patients with stage III renal cell carcinoma

H. Rammensee, S. Stevanović, A. Stenzl, 2012 .

RETRACTED ARTICLE: Structure and Characterization of Cancer pagurus Hemocyanin

S. Stevanović, L. Molin, E. Todorovska, 2015, Marine Biotechnology.

Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma

H. Rammensee, S. Stevanović, H. Salih, 2020, Blood Cancer Journal.

H. Rammensee, S. Stevanović, A. Marcu, 2020, Molecular & Cellular Proteomics.

Excreted Cytoplasmic Proteins Contribute to Pathogenicity in Staphylococcus aureus

S. Stevanović, F. Götz, M. Di Marco, 2016, Infection and Immunity.

Argyrin F Treatment‐Induced Vulnerabilities Lead to a Novel Combination Therapy in Experimental Glioma

H. Rammensee, S. Stevanović, G. Tabatabai, 2021, Advanced Therapeutics.

Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids.

M Josten, S. Stevanović, H. Sahl, 1990, European journal of biochemistry.

Investigation of the active site of Escherichia coli beta-D-galactosidase by photoaffinity labelling.

S. Stevanović, J. Lehmann, G. Jung, 1992, Carbohydrate research.

SARS-CoV-2 T-cell epitopes define heterologous and COVID-19-induced T-cell recognition

H. Rammensee, S. Stevanović, O. Kohlbacher, 2020 .

The role of peptide presentation in the physiological function of HLA-G.

S. Stevanović, E. Lammert, C. Münz, 1999, Seminars in cancer biology.

The making of the dominant MHC class I ligand SYFPEITHI

H. Rammensee, S. Stevanović, H. Schild, 1998, European journal of immunology.

Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1

E. Thiel, H. Rammensee, S. Stevanović, 2006, Clinical Cancer Research.

Evolutionary Conserved Cathepsin E Substrate Specificity as Defined by N-Terminal and C-Terminal Sequencing of Peptide Pools

S. Stevanović, H. Schild, W. Keilholz, 1997, Biological chemistry.

Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa

S. Stevanović, P. Dolashka, Vesela Moshtanska, 2011, Peptides.

Arylomycins A and B, New Biaryl-Bridged Lipopeptide Antibiotics Produced by Streptomyces sp. Tue 6075. Part 2. Structure Elucidation.

S. Stevanović, D. Schmid, G. Nicholson, 2002 .

Immunogenicity and Immune Silence in Human Cancer

S. Stevanović, P. Raman, D. Monos, 2020, Frontiers in Immunology.

Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer

H. Rammensee, S. Stevanović, F. Fend, 2016, International Journal of Gynecologic Cancer.

Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry

S. Stevanović, L. Freudenmann, A. Marcu, 2018, Immunology.

Identification of tumor‐associated MHC class I ligands by a novel T cell‐independent approach

H. Rammensee, S. Stevanović, M. Schirle, 2000, European journal of immunology.

HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)

H. Rammensee, S. Stevanović, L. Kanz, 2014, Proceedings of the National Academy of Sciences.

Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells.

S. Stevanović, M. Pfreundschuh, C. Wagner, 2005, Blood.

Identification and Characterization of Legionella pneumophila Phospholipases A

S. Stevanović, Sangeeta Banerji, A. Flieger, 2006 .

Tumor-associated MICA is shed by ADAM proteases.

H. Rammensee, S. Stevanović, A. Ludwig, 2008, Cancer research.

Two Preferentially Expressed Proteins Protect Vascular Endothelial Cells from an Attack by Peptide-Specific CTL

A. von Eckardstein, L. Rohrer, S. Stevanović, 2012, The Journal of Immunology.

High-density preculture of PBMCs restores defective sensitivity of circulating CD8 T cells to virus- and tumor-derived antigens.

S. Stevanović, C. Scholz, S. Hackenberg, 2015, Blood.

Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices

H. Rammensee, S. Stevanović, M. Di Marco, 2017, The Journal of Immunology.

A vaccine targeting mutant IDH1 induces antitumour immunity

S. Stevanović, A. Riemer, W. Wick, 2014, Nature.

LC-MS-based Protein and Peptide Quantification Using Stable Isotope Labels: From ICAT in General to Differential N-terminal Coding (dNIC) in Particular

S. Stevanović, A. Weinzierl, 2006, Biotechnology & genetic engineering reviews.

MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies.

S. Stevanović, M. Nielsen, D. Clements, 2017, Journal of proteome research.

Spontaneous Peripheral T-cell Responses toward the Tumor-Associated Antigen Cyclin D1 in Patients with Clear Cell Renal Cell Carcinoma

S. Stevanović, H. Moch, M. van den Broek, 2013, Cancer Immunology Research.